Trials / Unknown
UnknownNCT02255669
Fully Covered SEMS Versus Partially Covered SEMS With Anti-migration System for Malignant Distal Biliary Obstruction
Comparison Between Fully Covered and Partially Covered Self-expandable Metal Stents With Anti-migration System for Malignant Distal Biliary Obstruction
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 106 (estimated)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the duration of stent patency between partially covered and fully covered SEMS for palliation of malignant distal bile duct obstruction.
Detailed description
Endoscopic stent placement has been used as a principle palliative method in patients with unresectable distal malignancy biliary obstruction. It has been pivotal in providing relief from obstructive jaundice, improving the quality of life, and allowing the maintenance of chemotherapy. Although SEMSs have been reported to be superior to plastic stents in terms of stent patency, they still have some debatable issues ; in uncovered SEMS, stent occlusion due to epithelial hyperplasia and tumor ingrowth through the metal mesh is a frequent problem, whereas covered SEMSs are prone to migration. The aim of the current study is to compare the duration of stent patency between partially covered and fully covered SEMS as a primary objective, and investigate overall patient survival, stent occlusion rate, and incidence of adverse events including stent dysfunction as secondary objectives.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | partially covered SEMS | Used for palliation of inoperable malignant distal bile duct obstruction. |
| DEVICE | fully covered SEMS | Used for palliation of inoperable malignant distal bile duct obstruction. |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2016-10-01
- Completion
- 2016-10-01
- First posted
- 2014-10-02
- Last updated
- 2015-02-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02255669. Inclusion in this directory is not an endorsement.